Biosimilars, also known as follow-on biologics, are the subsequent versions of innovative biological medicine that are introduced after the expiry of the original medicine's patent. The development of biosimilars is a complex and expensive process, but it has potential to improve the accessibility of life-saving treatments. Emerging technological trends in the biosimilar sector are redefining the way these medicines are developed, evaluated, and marketed. Given that India is a global hub for generic medicine, it is critical to examine the country's role in the rapidly evolving biosimilars landscape.
In recent years, the market for biosimilars or similar biologics, has seen significant expansion, particularly in India. India's biosimilars market size was valued at $349 million in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 25.2 per cent from 2022 to 2030 and will reach $2108 million by 2030.
India is one of the leading manufacturers of biosimilars, and has observed an increase in their use, improving the health of many patients suffering from a wide variety of diseases. The most significant advantage of biosimilars is that they cost less than the original drugs that they replicate.
An article noted that the expiration of patents on many key biologics by 2020 would provide a sizable opportunity for the development and use of biosimilars. With over one hundred biopharmaceutical companies engaged in the manufacturing and marketing of biosimilars, India has emerged as a global market leader in this segment. It was the first to approve a biosimilar back in 2000 for the treatment of hepatitis B- much before Europe and the United States.
هذه القصة مأخوذة من طبعة August 2024 من Bio Spectrum.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.
بالفعل مشترك ? تسجيل الدخول
هذه القصة مأخوذة من طبعة August 2024 من Bio Spectrum.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.
بالفعل مشترك? تسجيل الدخول
Bhavin Mukund Mehta Vice-Chairman steps in as of Pharmexcil
Pharmaceuticals Export Promotion Council of India (Pharmexcil), a leading authorised body of the Government of India for promotion of pharmaceutical exports from India has appointed Bhavin Mukund Mehta, Wholetime Director, Kilitch Drugs (India) Limited as the Vice-Chairman of the council.
Roche Pharma India appoints Rajwinder Mehdwan as new Country General Manager
Roche Pharma India has announced the appointment of Rajwinder (Rajji) Mehdwan as country General Manager, effective April 1, 2025. She will also join the CEETRIS (Central Eastern Europe, Turkey, Russia & Indian Subcontinent) region leadership team, reporting to Francois du Toit, Area Head of CEETRIS, Roche Pharmaceuticals.
Exploring Careers in Clinical Research: Pathways, Roles, and Future Prospects in India
With India's evolving regulatory landscape, business environment and technological advancements, the future of clinical research in the country is promising and full of potential. This is creating the demand for proficient researchers which is increasing and offering exciting career opportunities for individuals prepared to influence the future of Medicines, Vaccines, Diagnostics, and Medical Devices.
Biopharma Chromatography: Segregating Opportunities of all Sizes
Chromatography systems are essential in a variety of fields, including the biological sciences. Biopharma accounts for almost 30 per cent of this market, making it a key sector for chromatography systems. The main forces behind India's dominant market position would be the enabling government policies and the growing number of foreign research and industrial contracts. Beginning in 2028, India will create a demand for more than 1000 biopharma chromatography systems yearly.
We're on a mission to make India a global leader in Frontier Tech: Debjani Ghosh
“From AI breakthroughs revolutionising healthcare to bioengineering innovations addressing food security and renewable energy advancements driving sustainability, Frontier Technologies offer solutions to the world’s most pressing challenges,” said Debjani Ghosh, Distinguished Fellow & Chief Architect - NITI Frontier Tech Hub, NITI Aayog, New Delhi.
10 Women 'Power Players' of Bio Research & Policy
As revealed in Finance Minister Nirmala Sitharaman's Economic Survey 202425, for the first time in seven years, India’s female labour force participation rate (FLFPR) has seen a significant rise, jumping from 23.3 per cent in 2017-18 to 41.7 per cent in 2023-24.
"We recognise the growing demand for skilled talent in fields like Al, Gen Al, Robotics, and Data Analytics"
Takeda, a global leader in biopharmaceutical innovation from Japan has opened its Innovation Capability Center (ICC) in Bengaluru.
Metropolis & Roche introduce HPV DNA testing to accelerate cervical cancer screening
Metropolis Healthcare has announced its collaboration with Roche Diagnostics India and Neighbouring Markets to introduce the self-sampling human papillomavirus (HPV) DNA test for cervical cancer screening.
Shimadzu strengthens business operations in India with new plant in Bengaluru
In order to strengthen business operations in India, which is expected to experience high economic growth, Japan's Shimadzu Corporation will establish the manufacturing subsidiary Shimadzu Manufacturing India Private Limited (SMI) in Bengaluru, Karnataka.
JNCASR brings new system for wearable devices that can detect stress
Using a silver wire network on a stretchable material, scientists from Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR), Bengaluru, have developed a device that senses strain, mimics pain perception and adapts its electrical response accordingly.
